Deal postponed: Grifols SA’s acquisition of Talecris Biotherapeutics Holdings Corp.
The closing date for Spanish healthcare company Grifols SA’s acquisition of North Carolina-based Talecris Biotherapeutics Holdings Corp. has been extended until June 30, according to a report in BusinessWeek....To view the full article, register now.
Already a subscriber? Click here to view full article